Home About Us Management Product Pipeline Collaborators Contact Us

the Development of Placental Alkaline Phosphatase
to Treat Muscle Wasting and Complications

Our Mission

Provide recombinant placental alkaline phosphatase (PLAP) for millions of people to prevent their early death by safely reducing or even reversing muscle wasting caused by cancer, cancer therapies, obesity, type 2 diabetes, and/or old age.

A Key Point

In contrast to the prevailing view, our science strongly supports the view that to avoid cancer cachexia, suitable treatment of patients must preferably start right after tumor detection. PLAP is being developed, in part, toward that goal.